ACADIA Pharmaceuticals (ACAD) Weighs Takeover Options, Stock Vaults

ACADIA Pharmaceuticals Inc

shares jumped 8.3% to $39.08. The company is being bid on by several companies, AstraZeneca among one of those suitors, according to a report from the U.K Daily Mail late Friday. Sources say Acadia investors would not accept less than $60 per share. Share volume was two million, compared to an all-day average of 3.3 million